Hola,
Are you new here?

I have an account

¿Te ayudamos?

Ejemplos de búsqueda

Vídeos Explicativos

FETAL MONITORING

financed

Closed

Safe and accurate fetal monitoring

During gestation and birth, problems are encountered in up to 15% of all births. Most problems are related to fetal hypoxia and preterm birth. It is estimated that every year over 30.000 babies in Europe suffer from birth asphyxia... see more

31/10/2018

NEMO HEALTHCARE BV

4M€

Project Budget: 4M€

Project leader

NEMO HEALTHCARE BV No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

PARTICIPATION DEPralty Sin fecha límite de participación.

Financing granted El organismo H2020 notifico la concesión del proyecto The day 2018-10-31

PHC-12-2015: Clinical research for the validatio... Scope:Specific challenge: Biomarkers are used in clinical practice to describe both normal and patho...

I+D

Cerrada does 10 years

0% 100% 100%

characteristics of the participant

Este proyecto no cuenta con búsquedas de partenariado abiertas en este momento.

Private Information

No hay información privada compartida para este proyecto. Habla con el coordinador.

1 Participantes

NEMO HEALTHCARE BV

4.05M€ | Leader

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Project duration: 28 months Date Start: 2016-06-21
End date: 2018-10-31

Project leader

NEMO HEALTHCARE BV No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Project Budget 4M€

participation deadline Sin fecha límite de participación.

Project description During gestation and birth, problems are encountered in up to 15% of all births. Most problems are related to fetal hypoxia and preterm birth. It is estimated that every year over 30.000 babies in Europe suffer from birth asphyxia, despite the common use of monitoring. Recent Norwegian research (2013) revealed inadequate fetal monitoring is responsible for 50% of the cases where human error caused birth asphyxia (oxygen deficiency). It can be concluded that current monitoring technology does not detect vital information on fetal wellbeing, causing unnecessary risks which can eventually lead to fetal mortality. There is thus a clear market need for fetal monitoring technology that is accurate, safe (non-invasive) and easy to use. Nemo Healthcare, a high-tech startup company, is responding to this market need through the development of an innovative electrode patch and hardware/software module that can simultaneously record uterine activity and fetal heart rate. The solution of Nemo is characterized by unique and smart algorithms that can accurately and real-time filter contractions and the fetal heart rate from unprocessed abdominal electrophysiological signals, successfully eliminating noise or interference. The solution will be able to transfer the recorded data wirelessly. The solution will create a breakthrough in the field of fetal monitoring: it will result in better diagnoses, improved quality of care, a reduced number of birth-related problems, increased user friendliness (for medical staff as well as the patient) and lower healthcare cost (through remote monitoring, reduced treatment and avoidance of unnecessary surgery).

Conecta tu I+D

Entra hoy

Forgot your password?

Financing

Companies

CTIs/Universidades

Projects

researchers